Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Launched by ALL4CURE · Dec 22, 2022

Keywords

ClinConnect Summary

This clinical trial, called "Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma," is exploring how a program called All4Cure affects patients with multiple myeloma, a type of blood cancer. The main goal is to see if using All4Cure helps patients feel more involved and engaged in their own healthcare, which will be measured using a survey called the PAM-13. Participants will need to complete a few surveys online at different times throughout the study to share their experiences and thoughts about the program.

To take part in this trial, patients must be at least 18 years old, have a diagnosis of multiple myeloma, and be able to read and understand English. They should also have access to a device, like a computer or smartphone, to complete the surveys. Importantly, participants need to be under the care of a doctor who is part of the All4Cure program. The study is currently recruiting participants, so if you or someone you know is interested, it could be a valuable opportunity to contribute to understanding how technology can support patients in managing their condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. have a diagnosis of multiple myeloma.
• • 2. are aged 18 years and older.
• • 3. can read and e-consent to participate in the study.
• • 4. can speak English.
• • 5. can complete surveys at pre-specified intervals.
• • 6. have access to a device that would allow for the completion of surveys (including at home, at work, at the oncologist's office or elsewhere).
• • 7. are cared for by a physician who is enrolled in All4Cure.
• Exclusion Criteria:
• • 1. Patients will be excluded who are unable to engage with All4Cure or are already participants in All4Cure.